Key facts
- It has raised $2.5M; the latest was Early Stage VC ($2.5M) in Jul 2025.
- Notable investors include Joseph Kiani.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for CDX Medical Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for CDX Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CDX Medical Technologies
Developer of an advanced respiratory care platform designed to enhance the delivery and accessibility of extracorporeal life support. The company's platform features rapid deployment, integrated monitoring, and streamlined operation for critical care, enabling hospitals and healthcare providers to support patients needing ECMO therapy while improving workflow efficiency and expanding access to advanced respiratory interventions.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Website
- eleuso.com/
- Ownership
- Privately Held (backing)
CDX Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CDX Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CDX Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.